No significant associations were found between EGFR alterations and other clinicopathologic parameters of the patients and tumours, namely gender and age of the patients, tumour localization, histological type, wall penetration, the presence of lymph node metastasis, vascular invasion and tumour staging of the tumour. Here, EGFR is linked to neoplasm.